Single-cell DNA-seq depicts clonal evolution of multiple driver alterations in osimertinib-resistant patients

Abstract

Distinct molecular driver alterations at osimertinib resistance coexist with initial EGFR mutations in single cancer cells. The clonal evolution of cancer cell populations emphasized their heterogeneity leading to osimertinib relapse. Combining two targeted treatments is effective to achieve clinical benefit.